HKSE - Delayed Quote
HKD
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
5.670
+0.045
(+0.80%)
As of 10:20:34 AM GMT+8. Market Open.
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Han Yan
|
Executive Chairman | -- | -- | 1979 |
|
Mr. Wang Chi
|
CEO & Executive Director | 1.65M | -- | 1976 |
|
Mr. Zheng Yue
|
Executive Vice Chairman | 1.28M | -- | 1974 |
|
Ms. Fung Yi Tsang
|
CFO & Company Secretary | -- | -- | 1977 |
|
Ms. Shaochen Qu
|
General Counsel | -- | -- | 1985 |
Beijing Tong Ren Tang Chinese Medicine Company Limited
Office Tower, Convention Plaza
Room 1405-1409 1 Harbour Road
Wan Chai
Hong Kong
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 763
Description
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and Europe. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
Corporate Governance
Beijing Tong Ren Tang Chinese Medicine Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 12, 2026 at 12:00 AM UTC
Ex-Dividend Date
